100 studies found for:    Open Studies | "Conjunctivitis"
Show Display Options
Rank Status Study
21 Unknown  The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions
Conditions: Allergic Rhinitis;   Asthma;   Allergic Conjunctivitis
Intervention: Drug: Allergen(Tree, Grass, Weeds)
22 Unknown  Ocular Allergy Treatment Practical Impact Trial
Conditions: Allergic Conjunctivitis;   Rhinoconjunctivitis
Intervention: Drug: Alcaftadine
23 Unknown  The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel
Conditions: Allergic Rhinitis;   Asthma;   Allergic Conjunctivitis;   Atopic Dermatitis
Intervention:
24 Unknown  A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
Conditions: Allergic Rhinitis;   Allergic Conjunctivitis
Interventions: Biological: modified allergen extract;   Biological: Placebo
25 Recruiting Topical Tacrolimus in Vernal Keratoconjunctivitis
Condition: Vernal Keratoconjunctivitis
Intervention: Drug: Topical tacrolimus
26 Not yet recruiting The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot Evaluation
Condition: Allergic Rhinoconjunctivitis
Interventions: Drug: Grastek®;   Drug: Placebo
27 Recruiting Seasonal Differences in Nasal Mucus Proteome and Impact of Immunotherapy
Condition: Allergic Rhinoconjunctivitis
Intervention: Biological: Immunotherapy
28 Recruiting Cytokine Assay in Tears of Healthy Children and With Vernal Keratoconjunctivitis: Case Control Study and Monitoring of Cases at 6 Months
Conditions: Vernal Keratoconjunctivitis;   Healthy Children
Intervention: Procedure: Cytokins assay in tears
29 Recruiting Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis
Condition: Vernal Keratoconjunctivitis
Interventions: Drug: NOVA22007 ''Ciclosporin'';   Drug: Placebo
30 Recruiting Study for Evaluating Life Quality in Patients With Rhinoconjunctivitis
Condition: Allergic Rhinoconjunctivitis
Intervention:
31 Not yet recruiting A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber
Condition: Allergic Rhinoconjunctivitis
Interventions: Drug: SQ tree SLIT-tablet;   Drug: Placebo
32 Unknown  Allergic Eye Disease Tear Mediators
Condition: Allergic Eye Disease
Intervention: Drug: olopatadine
33 Recruiting Efficacy and Safety of LAIS® Mites Sublingual Tablets
Condition: Allergic Conditions
Intervention: Drug: LAIS®
34 Recruiting Fluorometholone as Ancillary Therapy for TT Surgery
Conditions: Trichiasis;   Trachoma;   Bilamellar Tarsal Rotation
Interventions: Drug: Fluorometholone 0.1% ophthalmic solution;   Other: Artificial tears (Placebo)
35 Recruiting A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial
Condition: Trachoma
Intervention: Other: Surveillance and treatment with azithromycin of newcomer and traveler families
36 Recruiting A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica
Condition: Rhinoconjunctivitis
Intervention: Biological: Allergovac depot with Parietaria judaica pollen extract
37 Recruiting Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma
Conditions: Rhinitis;   Rhinoconjunctivitis;   Asthma
Interventions: Biological: DP/MG/14-1;   Biological: DP/MG/14-2
38 Recruiting Phase II HDM-SPIRE Safety and Efficacy Study
Condition: Rhinoconjunctivitis
Interventions: Drug: HDM-SPIRE;   Drug: Placebo
39 Recruiting Paediatric Safety Study in Cat-PAD
Condition: Rhinoconjunctivitis
Interventions: Drug: Cat-PAD;   Drug: Placebo
40 Not yet recruiting Clinical Evaluation of Systane® Balance in Dry Eye Subjects
Condition: Dry Eye
Intervention: Other: Propylene Glycol 0.6% eye drops

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years